Jordi Ochando

Mount Sinai

Dr. Jordi Ochando obtained his PhD from the De Montfort University in Leicester and completed his post-doctoral training at Mount Sinai School of Medicine in New York, where he currently holds an Assistant Professor position. His laboratory investigates the origin, phenotype and function of myeloid cells that regulate immune response in murine models of human disease, and recently discovered that trained immunity represents a previously unrecognized pathway that prevents the induction of transplantation tolerance.
His laboratory has recently developed a novel revolutionary targeted therapeutic delivery approach in which drug-loaded nanobiologics that target myeloid cells in vivo, prevent trained immunity and induce long-term allograft acceptance with minimal immunosuppressive drug usage. This research represents a compelling framework for developing novel targeted therapies that modulate the immune response with the concomitant clinical applications in humans.